COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING T CELL EXHAUSTION

MULTIPLE BIOMARKER FOR CANCER DIAGNOSIS AND USE THEREOF

RECOMBINANT ENHANCED ANTIVIRAL RESTRICTORS

BIO-BASED PRODUCTION OF SUCCINIC ACID USING VIBRIO NATRIEGENS

PREPARATION OF NOVEL TRITERPENE ALCOHOL DERIVATIVES WITH ENHANCED BIOAVAILABILITY FOR CANCER, INFLAMMATION AND PAIN TREATMENT

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

PROTEIN DEGRADATION SYSTEM, COMPONENTS, AND METHODS

C2 Domain Therapeutics and Uses Thereof

PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE AND FIBROSIS

PKC-activating compounds for the treatment of neurodegenerative diseases

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

METHOD AND SYSTEM FOR PREDICTING COUPLING PROBABILITIES OF G-PROTEIN COUPLED RECEPTORS WITH G-PROTEINS

CALCIUM DEPENDENT PROTEIN KINASE CONSTRUCTS AND USES THEREOF

Peptides for treatment and prevention of nonalcoholic fatty liver disease and fibrosis

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

PKC-activating compounds for the treatment of neurodegenerative diseases

Peptides for treatment and prevention of hyperglycaemia

SCREENING SYSTEM AND METHODS FOR IDENTIFYING ENZYME SUBSTRATES AND MODULATORS OF ENZYME ACTIVITY

Ex vivo method of generating super regulatory T cells for the prevention of autoimmune disease

Method of treating melanoma using an inhibitor of an atypical protein kinase C

PKC-activating compounds for the treatment of neurodegenerative diseases

Method for target protein identification using thermal stability shift-based fluorescence difference in two-dimensional gel electrophoresis

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

COMPOSITIONS TARGETING PKC-THETA AND USES AND METHODS OF TREATING PKC-THETA PATHOLOGIES, ADVERSE IMMUNE RESPONSES AND DISEASES

Protein kinase C inhibitors and uses thereof

Therapeutic compositions for breast cancer containing protein kinase D1 inhibitor

Method of treating melanoma using an inhibitor of an atypical protein kinase C

Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways

Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion

SiRNA targeting PRK2, which is hepatitis C virus therapeutic agent

THERAPEUTIC COMPOSITIONS INCLUDING MODULATORS OF deltaPKC AND/OR epsilonPKC, AND USES THEREOF

Protein kinase C inhibitors and uses thereof

Modifications of peptide compositions to increase stability and delivery efficiency

Compositions and methods for specific regulation of pyruvate dehydrogenase kinase

Use of PKC-iota inhibitors for the treatment of breast cancer

MODULATION OF REGULATORY T CELL FUNCTION VIA PROTEIN KINASE C-eta

PKC-activating compounds for the treatment of neurodegenerative diseases

Genetically encoded fluorescent sensors for detecting intracellular signalling through diacylglycerol pathways

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

Pain treatment

Protein kinase C inhibitors and uses thereof

Compositions and methods for specific regulation of pyruvate dehydrogenase kinase

Prostate carcinogenesis predictor

Methods and Compounds for the Diagnosis and Treatment for Cancer

Prostate carcinogenesis predictor

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

Method for treatment of inflammatory disease and disorder

Modifications of peptide compositions to increase stability and delivery efficiency

Further use of protein kinase N beta

COMPOSITIONS AND METHODS FOR THE TREATMENT OF KRABBE AND OTHER NEURODEGENERATIVE DISEASES

PKC-activating compounds for the treatment of neurodegenerative diseases

Protein kinase C inhibitors and uses thereof

PROTEIN KINASE C PEPTIDE MODULATORS OF ANGIOGENESIS

PEPTIDES DERIVED FROM THE C2 DOMAIN OF EPSILON PKC AND METHODS OF USE, THEREOF

Further Use of Protein Kinase N Beta

Phosphorylation of histone H3 at threonine 11—a novel epigenetic mark for transcriptional regulation

RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid (siNA)

Methods of modulating angiogenesis

PKC-activating compounds for the treatment of neurodegenerative diseases

METHOD OF TREATING ACUTE ST-ELEVATION MYOCARDIAL INFARCTION WITH A DELTA PKC ANTAGONIST

Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same

METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

DETECTION OF PKC-IOTA AS A BIOMARKER FOR BRAIN TUMORIGENESIS

RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

PROSTATE CARCINOGENESIS PREDICTOR

RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)

RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)

Peptides derived from the C2 domain of epsilon PKC

Modifications of peptide compositions to increase stability and delivery efficiency

Methods for treating cancer targeting transglutaminase

Aptamer-mediated intracellular delivery of oligonucleotides

RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)

Methods of modulating angiogenesis

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent

Detection of PKC-iota as a biomarker for brain tumorigenesis

RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)

Protein kinase C peptide modulators of angiogenesis

Rna interference mediated inhibition of xiap gene expression using short interfering nucleic acid (sina)

Three-dimensional structure of the catalytic domain of protein kinase c theta, methods and uses thereof

Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina)

RNA interference mediated inhibition of cyclin dependent kinase-2 (CDK2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MAP kinase gene expression or expression of genes involved in MAP kinase pathway using short interfering nucleic acid (siNA)

Aptamer-mediated intracellular delivery of therapeutic oligonucleotides

Use of deltaPKC peptides for modulation of reactive oxygen species

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Polycationic compositions for cellular delivery of polynucleotides

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

Compositions and methods for detecting intracellular glucose and analogs thereof

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein kinase C alpha (PKC-alpha) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)